3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
16
Phase 4
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 3
1
Status
Terminated
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Melanoma
3
Skin Neoplasms
2
Carcinoma, Renal Cell
2
Neoplasm, Residual
1
Neoplasm Metastasis
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Interventions
Sirolimus
3
aldesleukin
2
Tacrolimus
2
Cyclosporine
2
relatlimab
1
oxycodone-acetaminophen
1
abobotulinumtoxinA
1
Vemurafenib
1
Sodium Chloride
1
Prednisone
1
Nivolumab
1
Mycophenolic Acid
1
Meloxicam
1
Ipilimumab
1
Interleukins
1
Interleukin-2
1
Fluorouracil
1
Everolimus
1
Bleomycin
1
Azathioprine
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Skin Neoplasms
×
aldesleukin
×
Clear all
NCT01856023
2023-12-05
PROCLIVITY02
Clinigen, Inc.
Phase 4
Terminated
29 enrolled
9 charts
NCT01683188
2021-02-01
PROCLIVITY01
Clinigen, Inc.
Phase 4
Terminated
53 enrolled